Evidence map›Paper›PMID 39955379›Full record

ArticleScientific reports2025

Phytochemical analysis, bioactivity, and molecular docking studies of Myrtus communis L. seeds and fruit peel extracts demonstrating antioxidant and anti-tyrosinase properties.

Belal O Al-Najjar, Fatma Elshibani, Mohamed A Sharkasi, Nouha El Shintiri, Esra El Naili, Munira Abdulsayid, Roya S Abozayed, Hamdoon A Mohammed

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Belal O Al-NajjarDepartment of Pharmaceutical Sciences, Faculty of Pharmacy, Al-Ahliyya Amman University, Amman, 19328, Jordan.
Fatma ElshibaniDepartment of Pharmacognosy, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Mohamed A SharkasiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Nouha El ShintiriDepartment of Pharmacology and Toxicology, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Esra El NailiDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, University of Benghazi, Benghazi, Libya.
Munira AbdulsayidPathology Department, College of Medicine, Derna University, Derna, Libya.
Roya S AbozayedDepartment of Pharmacognosy, Faculty of Pharmacy, Assalam International University, Benghazi, Libya.
Hamdoon A MohammedDepartment of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah, Qassim, 51452, Saudi Arabia. ham.mohammed@qu.edu.sa.ORCID 0000-0003-2896-6790

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Myrtus communis L, is an edible medicinal plant with fruit berries used to manufacture liquors, aromatise wine, and sweet foods, beside several folk-medicinal uses. The plant is also endemic to Libya, holds promise for its medicinal properties, including anti-inflammatory, antioxidant, wound healing, and appetising effects. This work aims to explore the phytoconstituents present in the seeds and fruit peels of Myrtus communis L by GC-MS and LC-ESI-MS analysis, respectively. The work also demonstrated the in vitro and in silico antioxidant and anti-tyrosinase activities of the plant extracts. GC-MS analysis indicated the presence of 11 fatty acids in the myrtle seeds representing 78.61% of the total seeds' fatty acid contents, where the unsaturated linolenic acid (C

Indexed as

AntioxidantsEnzyme InhibitorsFruitMonophenol MonooxygenaseMyrtusPhytochemicalsPlant ExtractsSeedsGas Chromatography-Mass SpectrometryMolecular Docking SimulationAntioxidantsEnzyme InhibitorsMonophenol MonooxygenasePhytochemicalsPlant ExtractsAntioxidant activityAntioxidantsDrug analysisGC-MSLC-ESI-MSMyrtus communis LTyrosinase inhibition

Identifiers

PMID39955379
PMCPMC11830023

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.